This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
MiPLA: Difference between revisions
>RoRoKey removed summary |
>RoRoKey pharmacology |
||
| Line 17: | Line 17: | ||
==Pharmacology== | ==Pharmacology== | ||
As with its structurally related Lysergamides, MiPLA principally acts as a 5-HT2A partial agonist, through which it exerts its psychedelic effects.[Citation needed] | |||
However, the role of these interactions and how they result in the psychedelic experience continues to remain an object of scientific elucidation. | |||
Owing to similarities in chemical structure, MIPLA and LSD have highly similar binding profiles at monoamine receptors. | Owing to similarities in chemical structure, MIPLA and LSD have highly similar binding profiles at monoamine receptors. | ||